Sale!

CDSN Gene Peeling Skin Syndrome Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CDSN Gene Peeling Skin Syndrome Type 1 Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the CDSN gene, which are linked to Peeling Skin Syndrome Type 1. This rare genetic disorder is characterized by chronic, spontaneous skin peeling due to a deficiency in the corneodesmosin protein, crucial for skin cell adhesion. The test plays a vital role in confirming the diagnosis, enabling personalized management plans, and providing essential information for family planning. Conducted with precision and confidentiality, the test costs 4400 AED and represents a significant step forward in the field of genetic diagnostics, offering hope and clarity to affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDSN Gene Peeling Skin Syndrome Type 1 Genetic Test

Test Name: CDSN Gene Peeling Skin Syndrome Type 1 Genetic Test

Components: DNA Labs UAE

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CDSN Gene Peeling Skin Syndrome Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDSN Gene Peeling Skin Syndrome Type 1 NGS Genetic DNA Test gene CDSN.

Test Details

The CDSN gene is associated with a condition called peeling skin syndrome type 1 (PSS1). PSS1 is a rare genetic disorder characterized by excessive skin peeling, especially on the palms and soles. It is caused by mutations in the CDSN gene, which provides instructions for producing a protein called corneodesmosin.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, allowing for a comprehensive evaluation of genetic variations. In the context of PSS1, NGS genetic testing can be used to identify mutations in the CDSN gene, providing a definitive diagnosis for individuals suspected of having the condition.

NGS genetic testing involves sequencing the DNA of the individual being tested and comparing it to a reference genome. By identifying specific variations or mutations in the CDSN gene, healthcare professionals can confirm a diagnosis of PSS1 and provide appropriate treatment and management options for affected individuals.

Test Name CDSN Gene Peeling skin syndrome type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDSN Gene Peeling skin syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDSN Gene Peeling skin syndrome type 1 NGS Genetic DNA Test gene CDSN
Test Details

The CDSN gene is associated with a condition called peeling skin syndrome type 1 (PSS1). PSS1 is a rare genetic disorder characterized by excessive skin peeling, especially on the palms and soles. It is caused by mutations in the CDSN gene, which provides instructions for producing a protein called corneodesmosin.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, allowing for a comprehensive evaluation of genetic variations. In the context of PSS1, NGS genetic testing can be used to identify mutations in the CDSN gene, providing a definitive diagnosis for individuals suspected of having the condition.

NGS genetic testing involves sequencing the DNA of the individual being tested and comparing it to a reference genome. By identifying specific variations or mutations in the CDSN gene, healthcare professionals can confirm a diagnosis of PSS1 and provide appropriate treatment and management options for affected individuals.